283 related articles for article (PubMed ID: 33195396)
61. Missense Variants of Uncertain Significance: A Powerful Genetic Tool for Function Discovery with Clinical Implications.
Sessa G; Ehlén Å; von Nicolai C; Carreira A
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359619
[TBL] [Abstract][Full Text] [Related]
62. Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.
Rosenthal EA; Ranola JMO; Shirts BH
Fam Cancer; 2017 Oct; 16(4):611-620. PubMed ID: 28534081
[TBL] [Abstract][Full Text] [Related]
63. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.
Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M
Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989
[TBL] [Abstract][Full Text] [Related]
64. Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.
Karachaliou N; Bracht JWP; Fernandez Bruno M; Drozdowskyj A; Gimenez Capitan A; Moran T; Carcereny E; Cobo M; Domine M; Chaib I; Ramirez JL; Camps C; Provencio M; Vergnenegre A; Lopez-Vivanco G; Majem M; Massuti B; Rosell R
J Thorac Oncol; 2019 Feb; 14(2):304-310. PubMed ID: 30472259
[TBL] [Abstract][Full Text] [Related]
65. PARP Inhibitors in Pancreatic Cancer: From Phase I to Plenary Session.
Patel R; Fein D; Ramirez CB; Do K; Saif MW
Pancreas (Fairfax); 2019; 3(1):e5-e8. PubMed ID: 32030362
[TBL] [Abstract][Full Text] [Related]
66. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
67. TP53 variants of uncertain significance: increasing challenges in variant interpretation and genetic counseling.
Bittar CM; Vieira IA; Sabato CS; Andreis TF; Alemar B; Artigalás O; Galvão HCR; Macedo GS; Palmero EI; Ashton-Prolla P
Fam Cancer; 2019 Oct; 18(4):451-456. PubMed ID: 31321604
[TBL] [Abstract][Full Text] [Related]
68. Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
Spearman AD; Sweet K; Zhou XP; McLennan J; Couch FJ; Toland AE
J Clin Oncol; 2008 Nov; 26(33):5393-400. PubMed ID: 18824701
[TBL] [Abstract][Full Text] [Related]
69. A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer.
Velázquez C; Esteban-Cardeñosa EM; Lastra E; Abella LE; de la Cruz V; Lobatón CD; Durán M; Infante M
Breast; 2019 Feb; 43():91-96. PubMed ID: 30521987
[TBL] [Abstract][Full Text] [Related]
70. PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer.
Dillon KM; Bekele RT; Sztupinszki Z; Hanlon T; Rafiei S; Szallasi Z; Choudhury AD; Mouw KW
NPJ Precis Oncol; 2022 Jun; 6(1):49. PubMed ID: 35768576
[TBL] [Abstract][Full Text] [Related]
71.
Krais JJ; Johnson N
Mol Cell Oncol; 2020; 7(5):1786345. PubMed ID: 32944641
[TBL] [Abstract][Full Text] [Related]
72. BRCA1 frameshift variants leading to extended incorrect protein C termini.
Nepomuceno TC; Foo TK; Richardson ME; Ranola JMO; Weyandt J; Varga MJ; Alarcon A; Gutierrez D; von Wachenfeldt A; Eriksson D; Kim R; Armel S; Iversen E; Couch FJ; Borg Å; Xia B; Carvalho MA; Monteiro ANA
HGG Adv; 2023 Oct; 4(4):100240. PubMed ID: 37718511
[TBL] [Abstract][Full Text] [Related]
73. PALB2 Genetic Variants: Can Functional Assays Assist Translation?
Southey MC; Rewse A; Nguyen-Dumont T
Trends Cancer; 2020 Apr; 6(4):263-265. PubMed ID: 32209438
[TBL] [Abstract][Full Text] [Related]
74. Cancer patients' experience of receiving variant of uncertain significance results: An Asian perspective.
Ishak ND; Shaw T; Li ST; Yuen J; Goh HX; Chua ZY; Suresh P; Que FVF; Zhang Z; Chiang J; Ngeow J
J Genet Couns; 2023 Oct; ():. PubMed ID: 37864575
[TBL] [Abstract][Full Text] [Related]
75. Uncertain, Not Unimportant: Callosal Dysgenesis and Variants of Uncertain Significance in
Woodring TS; Mirza MH; Benavides V; Ellsworth KA; Wright MS; Javed MJ; Ramiro S
Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34193621
[TBL] [Abstract][Full Text] [Related]
76. The strand exchange domain of tumor suppressor PALB2 is intrinsically disordered and promotes oligomerization-dependent DNA compaction.
Kyriukha Y; Watkins MB; Redington JM; Dastvan R; Uversky VN; Hopkins JB; Pozzi N; Korolev S
bioRxiv; 2024 May; ():. PubMed ID: 37333393
[TBL] [Abstract][Full Text] [Related]
77. Predicting the Effect of Variants of Unknown Significance in Molecular Tumor Boards with the VUS-Predict Pipeline.
Schlotzig V; Kornrumpf K; König A; Tucholski T; Hügel J; Overbeck TR; Beissbarth T; Koch R; Dönitz J
Stud Health Technol Inform; 2021 Sep; 283():209-216. PubMed ID: 34545838
[TBL] [Abstract][Full Text] [Related]
78. Germline mutations in apoptosis pathway genes in ovarian cancer; the functional role of a TP53I3 (PIG3) variant in ROS production and DNA repair.
Chaudhry SR; Lopes J; Levin NK; Kalpage H; Tainsky MA
Cell Death Discov; 2021 Mar; 7(1):62. PubMed ID: 33782397
[TBL] [Abstract][Full Text] [Related]
79.
Mäkelä R; Härmä V; Badra Fajardo N; Wells G; Lygerou Z; Sangfelt O; Kononen J; Rantala JK
Oncotarget; 2021 May; 12(11):1100-1109. PubMed ID: 34084283
[TBL] [Abstract][Full Text] [Related]
80. Structural and functional prediction, evaluation, and validation in the post-sequencing era.
Li C; Luo Y; Xie Y; Zhang Z; Liu Y; Zou L; Xiao F
Comput Struct Biotechnol J; 2024 Dec; 23():446-451. PubMed ID: 38223342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
